Production (Stage)
The Clorox Company
CLX
$130.88
-$0.02-0.02%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -8.05% | -15.28% | 27.13% | -5.75% | -5.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.05% | -15.28% | 27.13% | -5.75% | -5.27% |
| Cost of Revenue | -11.56% | -14.80% | 13.40% | -11.73% | -6.10% |
| Gross Profit | -3.26% | -15.89% | 48.43% | 2.33% | -4.13% |
| SG&A Expenses | -5.54% | -5.47% | 11.55% | -29.83% | -1.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -175.00% | -55.56% | -300.00% | 910.00% | -33.33% |
| Total Operating Expenses | -10.14% | -12.00% | 10.98% | -6.93% | -4.97% |
| Operating Income | 6.64% | -31.18% | 313.51% | 2.33% | -7.38% |
| Income Before Tax | 704.76% | 74.26% | 510.34% | 16.03% | 82.86% |
| Income Tax Expenses | 687.50% | 7.50% | 1,750.00% | -3.57% | 122.22% |
| Earnings from Continuing Operations | 482.00% | 102.08% | 312.00% | 22.10% | 76.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -400.00% | 66.67% | -33.33% | 0.00% | 50.00% |
| Net Income | 464.71% | 107.53% | 350.00% | 22.73% | 75.83% |
| EBIT | 6.64% | -31.18% | 313.51% | 2.33% | -7.38% |
| EBITDA | 4.23% | -27.71% | 166.67% | 0.97% | -6.58% |
| EPS Basic | 467.28% | 108.23% | 350.54% | 22.25% | 75.94% |
| Normalized Basic EPS | 3.94% | -29.82% | 478.85% | 2.63% | -5.70% |
| EPS Diluted | 465.41% | 105.63% | 370.41% | 22.16% | 75.99% |
| Normalized Diluted EPS | 3.35% | -30.07% | 477.82% | 2.69% | -5.70% |
| Average Basic Shares Outstanding | -0.71% | -0.33% | -0.14% | 0.39% | 0.49% |
| Average Diluted Shares Outstanding | -0.15% | 0.03% | 0.02% | 0.33% | 0.49% |
| Dividend Per Share | 1.67% | 1.67% | 1.67% | 1.67% | 1.69% |
| Payout Ratio | 1.28% | -0.51% | -0.77% | -0.17% | -3.19% |